Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (78)
- Therapeutic goods regulation (18)
- Prescription medicines (16)
- Over the counter (OTC) medicines (15)
- Complementary medicines (12)
- Legislation (12)
- Advisory bodies and committees (11)
- Non-prescription medicines (11)
- Listed medicines (9)
- Labelling and packaging (6)
- Manufacturing (6)
- In Vitro Diagnostic medical devices (IVDs) (4)
- Medical devices safety (4)
- Advertising (3)
- Australian Register of Therapeutic Goods (ARTG) (3)
- Biological medicines (3)
- Medicine safety (3)
- Sunscreens (3)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Registered complementary medicines (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Use the filters or search function to help find relevant consultations.
Search
253 result(s) found, displaying 26 to 50
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), meeting of the Advisory Committee on Chemicals Scheduling (ACCS), or a joint meeting of these two committees.
-
ConsultationWe are seeking your feedback on proposed changes to clarify Clinical Decision Support System (CDSS) software regulation.
-
ConsultationThis consultation is for interim decisions made in relation to substances that were discussed at the NOVEMBER 2023 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS)
-
ConsultationWe are consulting to better understand the nature, extent and urgency of problems with the supply of medicines, including shortages and discontinuations of medicines in Australia.
-
ConsultationWe are seeking feedback on whether certain international scientific guidelines should be adopted.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), meeting of the Advisory Committee on Chemicals Scheduling (ACCS), or a joint meeting of these two committees.
-
ConsultationWe are seeking feedback on two new quality standards for MDMA and psilocybin that will be registered as legislative instruments, as Therapeutic Goods Orders (TGOs). This consultation closes on 31 January 2024.
-
ConsultationHave your say on proposed amendments to the Poisons Standard, to be considered at advisory committees in November 2023.
-
ConsultationWe conducted a public consultation to seek feedback from interested parties on proposed changes to the requirements of ingredients used in listed (low-risk) medicines.
-
ConsultationWe sought feedback on the proposed new ‘Guidelines for the Quality of Listed Probiotic Medicines’.
-
ConsultationThe TGA is sought feedback on how we select medical device applications for audit and how we conduct these audits.
-
ConsultationThe TGA periodically reviews requirements for medical devices to ensure they continue to be appropriate. Closing 28 July 2023.
-
ConsultationThe TGA is seeking feedback on proposed clarification and updates to the regulation of sunscreens. Closing date: 31 May 2023
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 17 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2023-24 financial year. Closing date: 20 March 2023
-
ConsultationThe TGA is seeking feedback on improvements to the therapeutic goods recalls process. Closing 13 March 2023.
-
ConsultationThis consultation is for the interim decision in relation to paracetamol which was discussed at the November 2022 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThis consultation is for interim decisions made in relation to the other substances that were discussed at the November 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 3 February 2023
-
ConsultationThe TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products (NVPs) in Australia.
-
ConsultationThe TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.